Cochrane Evidence Synthesis and Methods ►

Oral and intranasal aspirin desensitisation for non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease

To assess the effectiveness of oral or intranasal aspirin desensitisation, as monotherapy or as adjunctive therapy, in adult patients with NSAID-exacerbated respiratory disease.

This is a protocol.

Health topics:

Ear, nose & throat > Nose & sinus > Other nose & sinus disorders

Published:

19 November 2019

Authors:

Gan K, Lourijsen E, Avdeeva K, Fokkens W

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Gan K, Lourijsen E, Avdeeva K, Fokkens W. Oral and intranasal aspirin desensitisation for non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease. Cochrane Database of Systematic Reviews 2019, Issue 11. Art. No.: CD013476. DOI: 10.1002/14651858.CD013476